Everest Medicines (01952) Announces Share Capital Movements for October 2025

Bulletin Express11-06

Everest Medicines Limited (stock code: 01952) has reported its monthly return on equity securities for the period ended 31 October 2025. The total authorised share capital remained at 500,000,000 ordinary shares with a par value of USD 0.0001, equivalent to USD 50,000.

The number of issued ordinary shares rose from 353,535,381 to 353,548,381, reflecting an increase of 13,000 shares. These new shares resulted from the exercise of options under the post-IPO share option scheme, raising HKD 254,092.

As of 31 October 2025, 21,841,838 shares could be issued through the post-IPO share option scheme, with 173,573 shares under the pre-IPO option plan. Additionally, 3,340,941 shares could be issued via restricted stock units under the pre-IPO plan, while 1,873,212 shares could be issued under the post-IPO share award scheme.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124671377?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 19:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124671377","market":"hk","top_or_hot":-1,"title":"Everest Medicines (01952) Announces Share Capital Movements for October 2025","media":"Bulletin Express","content":"<p>Everest Medicines Limited (stock code: 01952) has reported its monthly return on equity securities for the period ended 31 October 2025. The total authorised share capital remained at 500,000,000 ordinary shares with a par value of USD 0.0001, equivalent to USD 50,000.</p>\n<p>The number of issued ordinary shares rose from 353,535,381 to 353,548,381, reflecting an increase of 13,000 shares. These new shares resulted from the exercise of options under the post-IPO share option scheme, raising HKD 254,092.</p>\n<p>As of 31 October 2025, 21,841,838 shares could be issued through the post-IPO share option scheme, with 173,573 shares under the pre-IPO option plan. Additionally, 3,340,941 shares could be issued via restricted stock units under the pre-IPO plan, while 1,873,212 shares could be issued under the post-IPO share award scheme.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Everest Medicines (01952) Announces Share Capital Movements for October 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEverest Medicines (01952) Announces Share Capital Movements for October 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-06 19:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Everest Medicines Limited (stock code: 01952) has reported its monthly return on equity securities for the period ended 31 October 2025. The total authorised share capital remained at 500,000,000 ordinary shares with a par value of USD 0.0001, equivalent to USD 50,000.</p>\n<p>The number of issued ordinary shares rose from 353,535,381 to 353,548,381, reflecting an increase of 13,000 shares. These new shares resulted from the exercise of options under the post-IPO share option scheme, raising HKD 254,092.</p>\n<p>As of 31 October 2025, 21,841,838 shares could be issued through the post-IPO share option scheme, with 173,573 shares under the pre-IPO option plan. Additionally, 3,340,941 shares could be issued via restricted stock units under the pre-IPO plan, while 1,873,212 shares could be issued under the post-IPO share award scheme.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"云顶新耀","start_time":0,"source_url":"","article_id":"1124671377","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124671377","pubTimestamp":1762428105,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Everest Medicines Limited (stock code: 01952) has reported its monthly return on equity securities for the period ended 31 October 2025. The total authorised share capital remained at 500,000,000...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"珠峰医药(01952)公布2025年10月股本变动","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"Everest Medicines Limited (stock code: 01952) has reported its monthly return on equity securities for the period ended 31 October 2025. The total authorised share capital remained at 500,000,000 ordinary shares with a par value of USD 0.0001, equivalent to USD 50,000.\nThe number of issued ordinary shares rose from 353,535,381 to 353,548,381, reflecting an increase of 13,000 shares. These new shares resulted from the exercise of options under the post-IPO share option scheme, raising HKD 254,092.\nAs of 31 October 2025, 21,841,838 shares could be issued through the post-IPO share option scheme, with 173,573 shares under the pre-IPO option plan. Additionally, 3,340,941 shares could be issued via restricted stock units under the pre-IPO plan, while 1,873,212 shares could be issued under the post-IPO share award scheme.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124671377","isCrawlerRequest":true}